McMillan Office’s Axcelis ACLS Stock Holding History

McMillan Office’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.49K	Hold	29	–	–	﹤0.01%	427
2026 Q1	$2.7K	Hold	29	–	–	﹤0.01%	443
2025 Q4	$2.33K	Buy	+29	New	+$2.43K	﹤0.01%	441

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.11B AUM 38.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

McMillan Office's ACLS Position: Q2 2026 in Review

McMillan Office held its Axcelis (ACLS) position steady in Q2 2026 at 29 shares worth $5.49K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

McMillan Office first reported a position in ACLS in Q4 2025 and has held it in 3 quarters since. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

McMillan Office held 29 shares of Axcelis worth $5.49K as of Q2 2026.
McMillan Office left its Axcelis share count unchanged in Q2 2026.
Axcelis made up ﹤0.01% of McMillan Office's portfolio in Q2 2026, its #427 holding.
McMillan Office first reported a position in Axcelis in Q4 2025 and has held it in 3 quarters since.
443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.